← Leaderboards
Mohamed H Sayegh
University Of Pennsylvania
$38,781,302
Attributed
$38,781,302
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.3M · FY2005–12$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$45,027,236 · 11
By mechanism
U01$28,314,685 · 1
P01$9,693,810 · 6
R01$7,017,401 · 3
M01$1,340 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Laurence A Turka$19,677,777
- Michael R Rickels$10,133,718
- Brendon M Baker$2,464,826
- Kang I Ko$2,736,710
- Ali Naji$46,943,355
Others in their field
Top investigators on “Chimeric Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$26,234,170
- Robert A Wood · Johns Hopkins University$24,963,233
- Larry Arthur$22,516,306
- Anne Moscona · Mount Sinai School Of Medicine Of Nyu$17,953,641
- Gary B. Ruvkun · Massachusetts General Hospital$17,006,862
Research focus
Chimeric ProteinsT-LymphocyteIn VivoBaseMediatingAllograftingTransplantationPlayAlloantigenIsoimmunityCytokineMemoryCellsT-Cell ActivationPrimatesResponsePathway InteractionsImmune ResponseOrgan TransplantationCardiacAcuteChronicNatural ImmunosuppressionSolid
Grant awards (46)
Novel Therapies to Improve Renal and Cardiac Allograft Outcomes$2,970,192
U01 · FY2012 · AI · contact PI
Role of Negative T Cell Costimulatory Pathways in Allograft Rejection and Toleran$381,076
R01 · FY2012 · AI · contact PI
Novel Therapies to Improve Renal and Cardiac Allograft Outcomes$3,039,178
U01 · FY2011 · AI · contact PI
Role of Novel T Cell Costimulatory Pathways in Allograft Rejection and Tolerance$470,272
P01 · FY2011 · AI · contact PI
The Role of TIM-1: TIM-4 Pathway in Allograft Rejection and Tolerance$404,539
R01 · FY2011 · AI · contact PI
Role of Negative T Cell Costimulatory Pathways in Allograft Rejection and Toleran$381,076
R01 · FY2011 · AI · contact PI
Novel Therapies to Improve Renal and Cardiac Allograft Outcomes$2,241,049
U01 · FY2010 · AI · contact PI
Role of Novel T Cell Costimulatory Pathways in Allograft Rejection and Tolerance$540,924
P01 · FY2010 · AI · contact PI
The Role of TIM-1: TIM-4 Pathway in Allograft Rejection and Tolerance$408,625
R01 · FY2010 · AI · contact PI
Role of Negative T Cell Costimulatory Pathways in Allograft Rejection and Toleran$384,925
R01 · FY2010 · AI · contact PI
Novel Therapies to Improve Renal and Cardiac Allograft Outcomes$2,322,378
U01 · FY2009 · AI · contact PI
Novel Therapies of Chronic Allograft Dysfunction$2,144,800
U01 · FY2009 · AI · contact PI
Role of Novel T Cell Costimulatory Pathways in Allograft Rejection and Tolerance$527,497
P01 · FY2009 · AI · contact PI
Role of Novel T Cell Costimulatory Pathways in Allograft Rejection and Tolerance$514,829
P01 · FY2009 · AI · contact PI
The Role of TIM-1: TIM-4 Pathway in Allograft Rejection and Tolerance$412,756
R01 · FY2009 · AI · contact PI
Role of Negative T Cell Costimulatory Pathways in Allograft Rejection and Toleran$388,813
R01 · FY2009 · AI · contact PI
Novel Therapies of Chronic Allograft Dysfunction$3,228,624
U01 · FY2008 · AI · contact PI
Role of Novel T Cell Costimulatory Pathways in Allograft Rejection and Tolerance$502,382
P01 · FY2008 · AI · contact PI
The Role of TIM-1: TIM-4 Pathway in Allograft Rejection and Tolerance$412,756
R01 · FY2008 · AI · contact PI
Role of Negative T Cell Costimulatory Pathways in Allograft Rejection and Toleran$388,813
R01 · FY2008 · AI · contact PI
Novel Therapies of Chronic Allograft Dysfunction$3,241,031
U01 · FY2007 · AI · contact PI
Role of Novel T Cell Costimulatory Pathways in Allograft Rejection and Tolerance$503,525
P01 · FY2007 · AI · contact PI
The Role of TIM-1: TIM-4 Pathway in Allograft Rejection and Tolerance$437,750
R01 · FY2007 · AI · contact PI
Novel Therapies of Chronic Allograft Dysfunction$3,287,345
U01 · FY2006 · AI · contact PI
Role of New Costimulatory Pathways in Graft Rejection$336,798
R01 · FY2006 · AI · contact PI
Novel Therapies of Chronic Allograft Dysfunction$3,261,996
U01 · FY2005 · AI
Immunopathogenesis of Chronic Allograft Rejection$1,343,052
P01 · FY2005 · AI
Role of New Costimulatory Pathways in Graft Rejection$344,903
R01 · FY2005 · AI
DEVELOPMENT OF ANTIGEN-SPECIFIC ASSAYS INDICATIVE OF DONOR-SPECIFIC TOLERANCE$1,340
M01 · FY2005 · RR
Novel Therapies of Chronic Allograft Dysfunction$2,578,092
U01 · FY2004 · AI
Immunopathogenesis of Chronic Allograft Rejection$1,303,933
P01 · FY2004 · AI
Role of New Costimulatory Pathways in Graft Rejection$344,903
R01 · FY2004 · AI
Immunopathogenesis of Chronic Allograft Rejection$1,265,954
P01 · FY2003 · AI
INTRATHYMIC TRANSPLANTATION TOLERANCE BY MHC PEPTIDES$353,639
R01 · FY2003 · AI
Role of New Costimulatory Pathways in Graft Rejection$344,903
R01 · FY2003 · AI
Immunopathogenesis of Chronic Allograft Rejection$1,096,213
P01 · FY2002 · AI
Role of New Costimulatory Pathways in Graft Rejection$344,081
R01 · FY2002 · AI
INTRATHYMIC TRANSPLANTATION TOLERANCE BY MHC PEPTIDES$324,982
R01 · FY2002 · AI
T Cell Costimulatory Pathways in Rejection/Tolerance$0
P01 · FY2002 · AI
Mechanisms of chronic allograft rejection$0
P01 · FY2002 · AI
Immunopathogenesis of Chronic Allograft Rejection$1,236,782
P01 · FY2001 · AI
INTRATHYMIC TRANSPLANTATION TOLERANCE BY MHC PEPTIDES$316,346
R01 · FY2001 · AI
Mechanisms of chronic allograft rejection$0
P01 · FY2001 · AI
ANTIGEN PRESENTING CELLS AND COSTIMULATORY BLOCKADE FOR TOLERANCE INDUCTION$0
P01 · FY2001 · AI
ANTIGEN PRESENTING CELLS AND COSTIMULATORY BLOCKADE FOR TOLERANCE INDUCTION$388,447
P01 · FY2000 · AI
INTRATHYMIC TRANSPLANTATION TOLERANCE BY MHC PEPTIDES$305,717
R01 · FY2000 · AI